Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–16 of 16 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06237452
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, C. Diff Infection, +17 more
- Locations
-
- Metro Infectious Disease Consultants Huntsville, Alabama, United States
- Advanced Gastroenterology, P.C. Chandler, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- GI Alliance Sun City, Arizona, United States
NCT07285213
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Chula Vista, California, United States
- Research Site Sacramento, California, United States
- Research Site Torrance, California, United States
NCT07613645
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
NCT04305769
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridia Difficile Colitis, +12 more
- Locations
-
- UVA Health Systems Charlottesville, Virginia, United States
- Carilion Clinic Roanoke, Virginia, United States
Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy
NCT06884748
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- Daniel Stein Milwaukee, Wisconsin, United States
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
NCT05852587
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +12 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
NCT06799039
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +9 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
NCT06794944
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +12 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection
NCT04781387
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- 131 Fullerton, California, United States
- 117 Lancaster, California, United States
- 143 Mission Hills, California, United States
- 138 Orange, California, United States
NCT04668014
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT03788434
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, CDI, +9 more
- Locations
-
- Phoenix Clinical, LLC Phoenix, Arizona, United States
- Mayo Clinic, Clinical Studies Unit Phoenix, Arizona, United States
- NEA Baptist Clinic Jonesboro, Arkansas, United States
- Alliance Research Institute Canoga Park, California, United States
ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection
NCT03183141
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +10 more
- Locations
-
- (Investigator site) Dothan, Alabama, United States
- (Investigator site) Sun City West, Arizona, United States
- (Investigator site) Mather, California, United States
- (Investigator site) Mountain View, California, United States
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
NCT03595553
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- University of Alabama - Birmingham Birmingham, Alabama, United States
- GI Alliance - Arizona Digestive Health - Sun City Sun City, Arizona, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Facey Medical Foundation Mission Hills, California, United States
NCT04675723
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +3 more
- Locations
-
- Kaiser Permanente Escondido, California, United States
- Gastroenterology Center of Connecticut Hamden, Connecticut, United States
- Metro Infectious Disease Consultants, LLC Burr Ridge, Illinois, United States
- Baptist Health Research Lexington, Kentucky, United States
Evaluation of GeoHAI Implementation
NCT05612672
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridioides Difficile Infection, +9 more
- Locations
-
- The Ohio State University Columbus, Ohio, United States